Condition: CABG · Myocardial Viability · Sponsor: Klinički Bolnički Centar Zagreb
Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.
This description comes directly from the study's public registry record.
Hrvoje Gasparovic, MD, PhD · +385 1 236 7529 · hrvoje.gasparovic@kbc-zagreb.hr
Always discuss trial participation with your own doctor first.
| University Hospital Center Zagreb | Zagreb, Croatia | Recruiting |
| University Hospital Center Zagreb | Zagreb, Croatia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07637266